Onconova Therapeutics, Inc. (NASDAQ: ONTX), a Phase 3 stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with an initial focus on myelodysplastic syndromes (MDS), today announced that the Company will release its first quarter financial results on Thursday, May 14, 2020, after the market closes. Management will host a conference call and live webcast at 4:30 p.m. ET on the same day to discuss thes